Incorporating flexibility into protein-ligand docking
Category
FP7 Project with U.S. partner
Short name and number
IFLPD (221208)
Area
Health
Description
One of the major goals of current drug discovery methods is the correct treatment of the flexibility of the receptor (i.e., protein) in small ligand docking. Computer-aided drug discovery through ligand docking-based virtual screening is already a key component in the lengthy and costly process of developing new drugs not only for academy but also for the pharmaceutical industries.
Participating Countries
Spain and United States.
Name of US Partner
THE SCRIPPS RESEARCH INSTITUTE
Contact
FUNDACIO PRIVADA INSTITUT DE RECERCA BIOMEDICA IRB (ES) / COARASA Carles